Adhesion prevention and
Haemostasis with 4DryField® PH
4DryField®PH is a single medical device that provides both adhesion prevention and haemostasis in one application.
The 4DF Technology
How does 4DryField® PH work?
Due to the molecular structure of 4DryField®PH, when liquid is absorbed (physiological saline solution), the microparticles form a gel that creates a temporary mechanical barrier against the formation of adhesions.
Arrest of bleeding / haemostasis
By absorbing liquid, 4DryField® PH causes a relative concentration of the patient’s own coagulation factors resulting in safe and fast haemostasis. Even with a 50% dilution of the blood, the coagulum induced by 4DryField® PH shows excellent stability.
Adhesion prevention4DryField®PH is indicated when the formation of postoperative adhesions needs to be prevented following surgery in cavities with a mesothelial lining (e.g. pericardium, chest cavity, abdominal cavity).
Arrest of bleeding / haemostasis 4DryField®PH is indicated in cases of surgical intervention or injury when the control of bleeding from arterioles, capillaries or veins is not effective or not practicable by means of conventional measures.Return to Home page
Publications and ReferencesLinks to all references and publications
Why does adhesion prevention make sense?
Adhesions are associated with postoperative complications, higher costs, and a heavier workload. In further surgery, adhesions may hamper a minimally invasive procedure and require more operating time e.g. for adhesiolysis. The risk of complications increases dramatically depending on the number and severity of previous operations. For patients, adhesions can result in chronic or recurrent pain, dyspareunia, infertility, and transit disorders – sometimes in the first year following surgery. The most serious complication is mechanical small intestine ileus, which is caused by adhesions in 65% to 75% of cases.
Video TrainingCheck the informational videos